Browse By

Tag Archives: financing

Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing

VANCOUVER, British Columbia, April 03, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its Pure Sunfarms (“PSF”) joint venture has finalized the expansion of its credit facility with its existing lender to $59 million, including accordion provisions of

MedMen Closes Senior Secured Convertible Financing and Provides Additional Corporate Updates

Announces closing of US$12,500,000 convertible note financing under existing Gotham Green credit facility Expands funding capacity under facility from US$250,000,000 to US$285,000,000 Receives final US$7,000,000 payment from divestiture of non-core Illinois cultivation asset, resulting in US$17,000,000 in total gross proceeds Appoints Tom Lynch, Partner and

Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

TORONTO, March 16, 2020 /PRNewswire/ – Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has closed the final tranche of its previously announced non-brokered private

Canada House Wellness Group Announces Closing of Second Tranche of its up to $3,000,000 Non-Brokered Unit Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, March 11, 2020 /CNW/ – Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company“), is pleased to announce that on March 11, 2020 it closed the second tranche (the “Second Tranche“) of its previously

James E. Wagner Cultivation Announces Second Convertible Security Funding Agreement With Lind Global Macro Fund, LP

KITCHENER, Ontario, March 11, 2020 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX VENTURE: JWCA; OTCQX: JWCAF), is pleased to announce that it has entered into a convertible security funding agreement dated March 10, 2020 (the “CSA”), for CDN$1.2 million (the “Convertible

Canopy Growth and TerrAscend Canada Enter Debt Financing Arrangement

Canopy Growth completes C$80.5 million loan to TerrAscend Canada Inc. SMITHS FALLS, ON, March 11, 2020 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED,NYSE:CGC) and TerrAscend Canada Inc. (“TerrAscend Canada”), a wholly owned subsidiary of TerrAscend Corp. (“TerrAscend”) (CSE:TER,OTCQX: TRSSF), today announced they have entered into a loan

Rapid Dose Therapeutics Announces Investment Agreement With Institutional Investor

BURLINGTON, Ontario, March 05, 2020 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) today announced that it has entered into an agreement for a drawdown equity financing facility (the “Investment Agreement”) with a single institutional investor. Subject to its terms and conditions and